Professor Paul Lee, founder of MSK Doctors, (+4403300010048) has released a new report analyzing the costs and investment value of Arthrosamid, an FDA-approved hydrogel injection offering long-lasting relief and improved mobility for patients suffering from knee osteoarthritis.
-- A highly respected Consulting Orthopaedic Surgeon and MSK Regenerative Specialist, Lee's in-depth report examines the cost-effectiveness of Arthrosamid, an FDA-approved treatment for chronic knee osteoarthritis. Available at select locations within the MSK Doctors network, including the London Cartilage Clinic on Harley Street, Arthrosamid is an innovative solution for patients seeking lasting knee pain relief and improved joint function.
Access the full report at https://mskdoctors.com/doctors/paul-lee/articles/arthrosamid-treatments-breaking-down-the-costs-and-investment-value
Arthrosamid is an injectable polyacrylamide hydrogel (iPAAG) developed to cushion the joint and provide lubrication, offering significant pain relief for enhanced mobility lasting for two years or more. By eliminating the need for repetitive treatments, prescription painkillers, and invasive surgery, this treatment stands out as a transformative option for knee osteoarthritis care.
“At MSK Doctors, we’re committed to advancing musculoskeletal treatments with innovative solutions like Arthrosamid,” says Lee. “While the initial cost of Arthrosamid may be higher than traditional interventions like corticosteroids, it’s essential to consider Arthrosamid's potential to reduce the need for repetitive treatments, which translates into cost savings over time.”
Professor Lee emphasizes the importance of personalized care and selecting clinics with specialized expertise in administering Arthrosamid injections. “The choice of clinic can significantly impact the success of the treatment,” he says. “Clinics like the London Cartilage Clinic on Harley Street, with their extensive MSK experience and 15-step injection protocol, offer the highest standards of safety, efficacy, and personalized patient care.”
In support of Arthrosamid’s potential, Lee points to a case study of an 81-year-old patient with advanced osteoarthritis who experienced remarkable improvement after a single Arthrosamid injection. MRI scans revealed a reduction in bone marrow lesions, demonstrating the treatment’s capacity to address complex joint issues in addition to managing pain and stiffness
Arthrosamid is considered a prudent investment for patients seeking long-term relief from knee osteoarthritis. With his latest report, Professor Lee provides valuable insights into its financial and health benefits, helping patients make informed decisions about their care.
A recent patient says, "I was dying with my knee pain, but thank god I came across MSK Doctors. Dr. Lee injected my knee, and now I am totally fine with zero pain in my knees."
To learn more or to book a consultation, visit https://mskdoctors.com
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Source: PressCable
Release ID: 89149736
In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.
